Literature DB >> 32644182

Febuxostat ameliorates methotrexate-induced lung damage.

S M Zaki1,2, G H A Hussein3, H M A Khalil4, W A Abd Algaleel5.   

Abstract

BACKGROUND: The intention of the present study was to assess the structural affection of the lung following methotrexate (MTX) overdose. The proposed underlying mechanisms involved in lung affection were studied. The possible modulation role of febuxostat over such affection was studied.
MATERIALS AND METHODS: Twenty-four rats were divided into three groups: control, MTX-treated, febuxostat-treated. The study was continued for 2 weeks. Lung was processed for histological and immunohistochemical (inducible nitric oxide synthase [iNOS] and cyclooxygenase [COX]-2) studies. Inflammatory markers (tumour necrosis factor alpha [TNF-a], interleukin 1 [IL-1]), Western blot evaluation of nuclear factor kappa B (NF-kB) and oxidative/antioxidative markers were done.
RESULTS: Methotrexate-treated group exhibited inflammatory cellular infiltrations, thickened interalveolar septa, dilated congested blood vessels, extravasated blood, and apoptosis. The collagen fibres content increased 3-fold. MTX induced lung affection through oxidative stress (increase MDA/decrease GSH, SOD) and apoptosis. It induced sterile inflammation through an increase of NF-kB (2-fold), IL-1 (3-fold) and TNF-a (3-fold), COX-2 cells (2.5-fold) and iNOS (6-fold). With the use of febuxostat, the normal lung architecture was observed with a bit thickened interalveolar septum and extravasated blood. The collagen fibres content was minimal. Decrement of oxidative stress and sterile inflammation (COX-2 cells and iNOS were comparable to the control group. NF-kB, IL-1 and TNF-a became higher by 34%, 64% and 100%).
CONCLUSIONS: The overdose of MTX displays inflammatory lung affection with residual fibrosis. It induces lung affection through oxidative stress, apoptosis and sterile inflammation. With the use of febuxostat, the normal lung architecture was preserved with a little structural affection or fibrotic residue. Febuxostat exerts its lung protection through its anti-inflammatory and antioxidant features.

Entities:  

Keywords:  febuxostat; lung; methotrexate

Year:  2020        PMID: 32644182     DOI: 10.5603/FM.a2020.0075

Source DB:  PubMed          Journal:  Folia Morphol (Warsz)        ISSN: 0015-5659            Impact factor:   1.183


  3 in total

1.  Chemical profiles with cardioprotective and anti-depressive effects of Morus macroura Miq. leaves and stem branches dichloromethane fractions on isoprenaline induced post-MI depression.

Authors:  Dalia I Hamdan; Samia S Hafez; Wafaa H B Hassan; Mai M Morsi; Heba M A Khalil; Yasmine H Ahmed; Omar A Ahmed-Farid; Riham A El-Shiekh
Journal:  RSC Adv       Date:  2022-01-26       Impact factor: 3.361

2.  High-Throughput mRNA Sequencing Reveals Potential Therapeutic Targets of Febuxostat in Secondary Injury After Intracerebral Hemorrhage.

Authors:  Xueyan Wang; Chenyu Zhang; Yuwen Li; Ting Xu; Jin Xiang; Yang Bai; Ying Zhang; Qi Wang; Tiejun Zhang; Linchuan Liao
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

3.  Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats.

Authors:  Neama M Albanawany; Doaa M Samy; Noha Zahran; Riham M El-Moslemany; Shefaa Mf Elsawy; Maha W Abou Nazel
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.